Dedifferentiated liposarcoma represents a distinct subtype of liposarc
oma and is characterized by the presence of abrupt transition from wel
l-differentiated liposarcoma to high-grade pleomorphic sarcoma (mostly
MFH-like). A key role for p53 in tumour progression of this subset of
liposarcomas has been suggested on the basis of p53 immunopositivity,
A series of 14 dedifferentiated liposarcomas has been investigated by
analysing the p53 gene and protein together with the p53-related mole
cules p21(Waf1) and mdm2, to verify whether the p53 pathway is involve
d in the development and progression of this tumour type, The results
indicate that the p53 gene is rarely involved in dedifferentiated lipo
sarcoma (7 per cent of cases analysed) and that low percentages of p53
immunopositivity are still compatible with integrity of the p53 gene.
This concept is also supported by the observed preservation of p21(Wa
f1) immunoreactivity in all but the p53-mutated cases. By contrast, md
m2 overexpression emerges as the most frequent abnormality in dediffer
entiated liposarcoma (57 and 78 per cent of cases in well-dedifferenti
ated and high-grade areas, respectively).